Lafayette General Medical Center announced Wednesday that it is one of the first hospitals in Louisiana to insert the smallest implantable cardiac monitoring device available.
The Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System is approximately one-third the size of a AAA battery, making it more than 80 percent smaller than other ICM's. While significantly smaller, the device is part of a powerful system that allows physicians to continuously, and wirelessly, monitor a patient's heart with 20 percent more data memory than its larger predecessor, Reveal® XT. Unlike its predecessors, it is implantable without requiring IV's, sedation or stitches.
Known as a loop recorder, the LINQ ICM monitors a patient's heart rate and rhythm, providing an electronic record of anything abnormal (up to three years, if needed). The device wirelessly alerts his or her physician after a patient-marked event or at scheduled intervals.
The Reveal LINQ system includes the new MyCareLink™ Patient Monitor, a simplified remote monitoring system with global cellular technology that transmits patients' cardiac diagnostic data to clinicians from nearly any location in the world.
“Being the first to use new technology in Acadiana is something we always take great pride in,” said Patrick J. Welch, M.D., the physician who performed the procedure. “But, this advancement ultimately means far better outcomes for our patients by reducing risks, improving our capabilities and providing greater longevity for cardiac patients.”
Dr. Welch performed the procedure with the help of Lafayette General's Cardiac Catheterization Lab staff and with assistance from Cardiovascular Institute of the South at Lafayette General, who helped facilitate use of the technology.
In addition to its continuous and wireless monitoring capabilities, the system provides remote monitoring through the Carelink® Network. Through the Carelink Network, physicians can request notifications to alert them if their patients have had cardiac events. The Reveal LINQ ICM is indicated for patients who experience symptoms such as dizziness, palpitation, syncope (fainting) and chest pain that may suggest a cardiac arrhythmia, and for patients at increased risk for cardiac arrhythmias.
Placed just beneath the skin through a small incision of less than 1 cm in the upper left side of the chest, the Reveal LINQ ICM is often nearly invisible to the naked eye once inserted. The device is placed using a minimally invasive insertion procedure, which simplifies the experience for both physicians and their patients. The Reveal LINQ ICM is MR-Conditional, allowing patients to undergo magnetic resonance imaging (MRI) if needed.